Glial cell-derived glutamate mediates autocrine cell volume regulation in the retina: activation by VEGF.
Astroglial cells are a source for gliotransmitters such as glutamate and ATP. We demonstrate here that gliotransmitters have autocrine functions in the regulation of cellular volume. Hypoosmotic stress in the presence of inflammatory mediators or oxidative stress, and during blockade or down-regulation of potassium channels, induces swelling of retinal glial cells. Vascular endothelial growth factor inhibits the osmotic swelling of glial cells in retinal slices or isolated cells. This effect was mediated by a kinase domain region/flk-1 receptor-evoked calcium dependent release of glutamate from glial cells, and subsequent stimulation of glial group I/II metabotropic glutamate receptors. Activation of kinase domain region/flk-1 or glutamate receptors evoked an autocrine swelling-inhibitory purinergic signaling cascade that was calcium-independent. This cascade involved the release of ATP and adenosine, and the activation of purinergic P2Y(1) and adenosine A1 receptors, resulting in the opening of potassium and chloride channels and inhibition of cellular swelling. The glutamatergic-purinergic regulation of the glial cell volume may be functionally important in the homeostasis of the extracellular space volume during intense neuronal activation which is associated with a swelling of neuronal cell structures in the retina. However, glial cell-derived glutamate may also contribute to the swelling of activated neurons since metabolic poisoning of glial cells by iodoacetate inhibits the neuronal cell swelling mediated by activation of ionotropic glutamate receptors.
Wurm
Antje
A
Paul Flechsig Institute of Brain Research, University of Leipzig, Leipzig, Germany.
Pannicke
Thomas
T
Wiedemann
Peter
P
Reichenbach
Andreas
A
Bringmann
Andreas
A
D000818:Animals; D048429:Cell Size / Q000187:drug effects; D003921:Diabetes Mellitus, Experimental / Q000473:pathology; D004195:Disease Models, Animal; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D008297:Male; D009457:Neuroglia / Q000187:drug effects* / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D020318:Rats, Long-Evans; D017208:Rats, Wistar; D017470:Receptors, Glutamate / Q000378:metabolism; D011983:Receptors, Purinergic / Q000378:metabolism; D015427:Reperfusion Injury / Q000473:pathology; D012160:Retina / Q000473:pathology*; D042442:Vascular Endothelial Growth Factors / Q000494:pharmacology*; D014867:Water / Q000378:metabolism
D017470:Receptors, Glutamate; D011983:Receptors, Purinergic; D042442:Vascular Endothelial Growth Factors; D014867:Water; D018698:Glutamic Acid